A detailed history of Ipsen Advisor Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ipsen Advisor Group LLC holds 4,479 shares of ABT stock, worth $601,440. This represents 0.46% of its overall portfolio holdings.

Number of Shares
4,479
Previous 4,341 3.18%
Holding current value
$601,440
Previous $576 Million 5.79%
% of portfolio
0.46%
Previous 0.5%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

BUY
$123.95 - $138.08 $17,105 - $19,055
138 Added 3.18%
4,479 $609 Million
Q1 2025

Apr 15, 2025

SELL
$111.1 - $140.22 $8,554 - $10,796
-77 Reduced 1.74%
4,341 $576 Million
Q4 2024

Feb 11, 2025

BUY
$111.93 - $119.39 $187,258 - $199,739
1,673 Added 60.95%
4,418 $500 Million
Q4 2022

Feb 10, 2023

BUY
$95.06 - $111.52 $260,939 - $306,122
2,745 New
2,745 $301 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $235B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ipsen Advisor Group LLC Portfolio

Follow Ipsen Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipsen Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ipsen Advisor Group LLC with notifications on news.